The global itraconazole market is slated to grow on the basis of increase in the incidence of fungal infections and research conducted regarding the development of advanced versions of itraconazole (ITZ).
The drug comes in the form of blue capsules, each one of which contains 100 mg and is generally consumed twice a day at 12-hour intervals. Itraconazole’s SPORANOX brand has a three-layered structure, which is complex as ITZ is insoluble and also sensitive to pH.
The companies operating in the itraconazole market are working toward developing itraconazole drugs based on the inference drawn by researchers regarding efficacy and safety of once-daily super-bioavailable itraconazole (SITZ)-130 mg in non-obese and obese patients living with glabrous tinea.
They are also exploring the discovery of advanced form of itraconazole capsules for delivering a higher percentage of active medicine at a smaller dose through ascertaining lesser inter-individual variability to translate to improved efficacy while managing fungal infections effectively and economically.
Itraconazole (ITZ) is referred to as an antifungal medication used for treating numerous fungal infections including blastomycosis, aspergillosis, paracoccidiodomycosis, and histoplasmosis. It can be orally administered or intravenously.
The common side-effects of itraconazole include diarrhea, abdominal pain, nausea, headache, and rashes. Severe side-effects may constitute heart failure, liver problems, allergic reactions such as anaphylaxis, and Stevens-Johnson Syndrome.
Itraconazole is on the WHO’s List of Essential Medicines.
Itraconazole is prescribed for various systemic infections such as candidiasis, aspergillosis, and cryptococcosis. These days, it is explored as one of the anticancer agents for those suffering from non-small lung cancer, basal cell carcinoma, and prostate cancer.
The ongoing trend comprises encapsulation of ITZ into functional polymeric nanoparticles for controlled release into macrophages in order to fight intracellular infections. It is expected to create constructive disruption in the intraconazole industry during the forecast period.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
As per NEJM Journal Watch, more than 6.5 individuals suffer from life-threatening fungal infections, out of which 2.5 million succumb to them. It further states that 500,000 cases of pneumocystosis were recorded per year, with 80% happening to those living with HIV infection.
The key players are devising various methods to expand the production of itraconazole, so as to reach out to the untapped geographies of Latin America, Middle East & Africa, and Asia Pacific.
Increase in frequency of fungal infections followed by the key participants engaging in extensive production of itraconazole drugs is thus catalyzing the itraconazole market.
Various clinical-stage biopharmaceutical companies are developing new inhaled therapies in order to address the problems pertaining to central and peripheral nervous system. They are coming up with antifungal itraconazole’s orally inhaled dry powder formulations to treat Allergic Bronchopulmonary Aspergillosis (ABPA) in patients suffering from asthma.
Along the above-mentioned lines, Pulmatrix has begun conducting phase 2 study of the itroconazole drug called PUR1900 in adults suffering from ABPA with sites in the U.S., France, Australia, and the U.K.
The company has also announced that it has published ‘Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data’ in the American Association of Pharmaceutical Scientists (AAPS) Journal.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest itraconazole market analysis, North America dominated the itraconazole landscape in 2023 and is expected to continue with its dominance during the forecast period. This is attributed to continuous upgradation of itraconazole therapeutics all over the U.S. and Canada.
Asia Pacific’s significant itraconazole market share is due to growing awareness about the importance of treating fungal infection on time. China and India are leading on this count and the status quo is expected to remain unchanged in the next few years.
The itraconazole market manufacturers are increasing the production of their itraconazole tablets to widen their consumer base.
Smilax Laboratories Limited, Chongquing Huabang Shengkai Pharmaceutical Co. Ltd., Ultratech Pharmaceuticals, Janssen Pharmaceuticals, Mylan N.V., Tianjin Lisheng Pharmaceutical Co., Ltd., Medisys Biotech, and Lepu Biopharma are some of the key players covered in the itraconazole market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 639.4 Mn |
| Market Forecast (Value) in 2034 | US$ 866.3 Mn |
| Growth Rate (CAGR) | 2.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 639.4 Mn in 2023
It is projected to grow at a CAGR of 2.8% from 2024 to 2034
Growing prevalence of fungal infection and extensive R&D activities being conducted
Hospital pharmacies segment accounted for the largest share in 2023
North America was the dominant region in 2023
Smilax Laboratories Limited, Chongquing Huabang Shengkai Pharmaceutical Co. Ltd., Ultratech Pharmaceuticals, Janssen Pharmaceuticals, Mylan N.V., Tianjin Lisheng Pharmaceutical Co., Ltd., Medisys Biotech, and Lepu Biopharma
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Itraconazole Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Itraconazole Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Itraconazole Market Analysis and Forecast, by Form
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Form, 2020-2034
6.3.1. Capsule
6.3.2. Cream
6.3.3. Tablet
6.3.4. Injection
6.4. Market Attractiveness Analysis, by Form
7. Global Itraconazole Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Gynecology
7.3.2. Dermatology
7.3.3. Others (Ophthalmology, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Itraconazole Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Itraconazole Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Itraconazole Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Form, 2020-2034
10.3.1. Capsule
10.3.2. Cream
10.3.3. Tablet
10.3.4. Injection
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Gynecology
10.4.2. Dermatology
10.4.3. Others (Ophthalmology, etc.)
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online Pharmacies
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Form
10.7.2. By Application
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Itraconazole Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Form, 2020-2034
11.3.1. Capsule
11.3.2. Cream
11.3.3. Tablet
11.3.4. Injection
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Gynecology
11.4.2. Dermatology
11.4.3. Others (Ophthalmology, etc.)
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Form
11.7.2. By Application
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Itraconazole Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Form, 2020-2034
12.3.1. Capsule
12.3.2. Cream
12.3.3. Tablet
12.3.4. Injection
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Gynecology
12.4.2. Dermatology
12.4.3. Others (Ophthalmology, etc.)
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Form
12.7.2. By Application
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Itraconazole Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Form, 2020-2034
13.3.1. Capsule
13.3.2. Cream
13.3.3. Tablet
13.3.4. Injection
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Gynecology
13.4.2. Dermatology
13.4.3. Others (Ophthalmology, etc.)
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Form
13.7.2. By Application
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Itraconazole Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Form, 2020-2034
14.3.1. Capsule
14.3.2. Cream
14.3.3. Tablet
14.3.4. Injection
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Gynecology
14.4.2. Dermatology
14.4.3. Others (Ophthalmology, etc.)
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Form
14.7.2. By Application
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Smilax Laboratories Limited
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Chongquing Huabang Shengkai Pharmaceutical Co. Ltd.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Ultratech Pharmaceuticals
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Janssen Pharmaceuticals
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Mylan N.V.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Tianjin Lisheng Pharmaceutical Co., Ltd.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Medisys Biotech
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Lepu Biopharma
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
List of Tables
Table 01: Global Itraconazole Market Size (US$ Mn) Forecast, by Form, 2020-2034
Table 02: Global Itraconazole Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global Itraconazole Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 04: Global Itraconazole Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Itraconazole Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Itraconazole Market Size (US$ Mn) Forecast, by Form, 2020-2034
Table 07: North America Itraconazole Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 08: North America Itraconazole Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 09: Europe Itraconazole Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Itraconazole Market Size (US$ Mn) Forecast, by Form, 2020-2034
Table 11: Europe Itraconazole Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 12: Europe Itraconazole Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 13: Asia Pacific Itraconazole Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Itraconazole Market Size (US$ Mn) Forecast, by Form, 2020-2034
Table 15: Asia Pacific Itraconazole Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific Itraconazole Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 17: Latin America Itraconazole Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Itraconazole Market Size (US$ Mn) Forecast, by Form, 2020-2034
Table 19: Latin America Itraconazole Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Latin America Itraconazole Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 21: Middle East & Africa Itraconazole Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Itraconazole Market Size (US$ Mn) Forecast, by Form, 2020-2034
Table 23: Middle East & Africa Itraconazole Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa Itraconazole Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
List of Figures
Figure 01: Global Itraconazole Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Itraconazole Market Revenue (US$ Mn), by Form, 2023
Figure 03: Global Itraconazole Market Value Share, by Form, 2023
Figure 04: Global Itraconazole Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global Itraconazole Market Value Share, by Application, 2023
Figure 06: Global Itraconazole Market Revenue (US$ Mn), by Distribution Channel, 2023
Figure 07: Global Itraconazole Market Value Share, by Distribution Channel, 2023
Figure 08: Global Itraconazole Market Value Share, by Region, 2023
Figure 09: Global Itraconazole Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Itraconazole Market Value Share Analysis, by Form, 2023 and 2034
Figure 11: Global Itraconazole Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Itraconazole Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global Itraconazole Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: Global Itraconazole Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 15: Global Itraconazole Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 16: Global Itraconazole Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Itraconazole Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Itraconazole Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Itraconazole Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Itraconazole Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Itraconazole Market Value Share Analysis, by Form, 2023 and 2034
Figure 22: North America Itraconazole Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America Itraconazole Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 24: North America Itraconazole Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Itraconazole Market Attractiveness Analysis, by Application, 2024-2034
Figure 26: North America Itraconazole Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 27: Europe Itraconazole Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Itraconazole Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Itraconazole Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Itraconazole Market Value Share Analysis, by Form, 2023 and 2034
Figure 31: Europe Itraconazole Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe Itraconazole Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 33: Europe Itraconazole Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Itraconazole Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe Itraconazole Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 36: Asia Pacific Itraconazole Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Itraconazole Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Itraconazole Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Itraconazole Market Value Share Analysis, by Form, 2023 and 2034
Figure 40: Asia Pacific Itraconazole Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific Itraconazole Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 42: Asia Pacific Itraconazole Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Itraconazole Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific Itraconazole Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 45: Latin America Itraconazole Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Itraconazole Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Itraconazole Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Itraconazole Market Value Share Analysis, by Form, 2023 and 2034
Figure 49: Latin America Itraconazole Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America Itraconazole Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 51: Latin America Itraconazole Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Itraconazole Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America Itraconazole Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 54: Middle East & Africa Itraconazole Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Itraconazole Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Itraconazole Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Itraconazole Market Value Share Analysis, by Form, 2023 and 2034
Figure 58: Middle East & Africa Itraconazole Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa Itraconazole Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 60: Middle East & Africa Itraconazole Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Itraconazole Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa Itraconazole Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Itraconazole Market
